Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo

Chinese Medical Journal

Volumn 116, Issue 12, 2003, Pages 1869-1874

  Zhang, Ping ^a   Wu, Dezheng ^a   Ge, Jian ^a   Zhu, Zhenyu ^b   Feng, Guanguang ^a   Yue, Tao ^b   Lin, Jianxian ^a   Zheng, Huling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anti angiogenesis; Corneal neovascularization; Endostatin; Gene therapy

Indexed keywords

ACID; ENDOSTATIN; LIPOSOME; PBLAST HENDOSTATIN; PBLAST MCS; POTASSIUM NITRATE; SILVER NITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUTERIZATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORNEA CELL; CORNEA EDEMA; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; FIBROBLAST; GENBANK; GENE IDENTIFICATION; GENE SEQUENCE; GENE THERAPY; GENETIC TRANSFECTION; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; RAT; SEQUENCE ALIGNMENT;

ANIMALS; CORNEAL NEOVASCULARIZATION; ENDOSTATINS; GENE THERAPY; HUMANS; RATS; RATS, WISTAR; TRANSFECTION;

EID: 0742289070     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Benelli U, Ross JR, Nardi M, et al. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 1997; 38:274-282.
2. Hayashi A, Popovich KS, Kim HC, et al. Role of protein tyrosine phosphorylation in rat corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997;235:460-467.
3. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998;43:245-269.
4. Kruse FE, Joussen AM, Rohrschneider K, et al. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 1998;236:461-466.
5. Maske R, Hill JC, Horak S. Mixed lymphocyte culture responses in rabbits undergoing corneal grafting and topical cyclosporin treatment. Cornea 1994;13:324-330.
6. Loughnan MS, Chatzistefanou K, Gonzalez EM, et al. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Austr New Zealand J Ophthalmol 1996;24:289-295.
7. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997:88:277-285.
8. Dhanabal M, Volk R, Ramchandran R, et al. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun 1999;258:345-352.
9. Ding I, Sun JZ, Fenton B, et al. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in Mca-4 murine mammary carcinomas. Cancer Res 2001;61: 526-531.
10. Blezinger P, Wang JJ, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nature Biotechnol 1999;17:343-348.
11. Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res 2000;60:1503-1506.
12. Sacco MG, Cato EM, Ceruti R, et al. Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice Gene therapy 2001;8:67-70.
13. Fox SB, Gatter KC, Harris AL. Tumour angiogenesis. J Pathol 1996;179:232-237.
14. Saarela J, Ylikarppa R, Rehn M, et al. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol 1998;16:319-328.